Dr. Hyo-Soo Kim and I discussed the HOST-BR trial on optimal DAPT duration and thrombosis-bleeding balance in ACS patients. 3-month DAPT reduced thrombosis vs. 1-month in high bleeding risk, and reduced bleeding vs. 12-month in low-risk patients March 29, 2025 2025 | ACC | Cardiology | Trial | Video Disclosures: TBD LBCT ACC25-HOST-BR HSKim 0328 UPLOADEDDownload Article Navigation Dr. Keyvan Karkouti and I discussed the FARES-II trial. PCC is superior to FP for hemostasis in managing excessive bleeding among cardiac surgery ptS with coagulopathy. Dr. Luke Laffin and I discuss: Efficacy Of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension On A Standardized Antihypertensive Medication Regimen
